We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF

48 hedge funds and large institutions have $44.2M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 10

1% more capital inflows, than outflows

Capital inflows: $5.68M | Capital outflows: $5.61M

0.93% more ownership

Funds ownership: 40.93% → 41.86% (+0.93%)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

2% less funds holding

Funds holding: 49 → 48 (-1)

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
19
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IDNA Hedge Fund Activity: Q2 2025 in Review

48 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2025, worth a combined $44.2M — down 0.51% from $44.4M a quarter earlier.

Fund positioning in IDNA was balanced in Q2 2025: 7 funds opened new positions, 7 closed out, 19 added to existing stakes and 10 trimmed.

The largest buyer was Portland Global Advisors, opening a new position worth an estimated $2.06M. The largest seller was Morgan Stanley, cutting an estimated $4.12M.

  • 48 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2025, down from 49 in Q1 2025.
  • Funds reported $44.2M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2025, down 0.51% quarter-over-quarter.
  • 7 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2025 and 7 closed out, a net change of 0 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2025 was Portland Global Advisors, an estimated $2.06M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2025 was Morgan Stanley, an estimated $4.12M sold.

Based on aggregated 13F filings for Q2 2025.